Starting point for a COVID drug is the 5000th protein structure decoded at BESSY II
Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analyzed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY I...
📰 Original Source
Read full article at Phys →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.